A call to the European Commission, the European Council, and the European Parliament was made regarding Hospital Exemptions (HE) for ATMPs. The importance of HEs for ATMPs is recognized all over Europe as they enable patients to receive treatments for (rare) diseases when there are no alternative treatments on the market. However, this regulation still requires improvement to further enhance ATMP development and create access to better healthcare. A Join Statement was written and signed by members from: EBMT, GoCART Coalition, Lymphoma Coalition, EBA, ESOT, CORE SOHO, TERAV, CTGCT, SANTAROS KLINIKOS, EU EYE, Clínic Barcelona | Universitat de Barcelona and DARE-NL. This statement lays-out five critical points that could improve the HE.